Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System
Clinical trial NCT05419817 · WITHDRAWN
Trial details
- NCT number
- NCT05419817
- Sponsor
- Haider Mahdi
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-08
- Primary completion
- 2025-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.